Annual Report 2021
IT IS IN OUR NATURE TO EXPLORE, TO REACH OUT INTO THE UNKNOWN. THE ONLY TRUE FAILURE WOULD BE NOT TO EXPLORE AT ALL.”
Ernest Shackleton
Led three British expeditions to the Antarctic

The Brain. The Last Great Frontier.

History has taught us that preparing for an expedition into the unknown takes more than raw courage. It takes the right equipment, the right leadership, the right vision and a crew that believes in you. Especially when you’re venturing into the wild uncharted territories of the human brain. We are Brain Canada, the national non-profit organization that supports Canada’s most brilliant brain researchers. We fund their bold explorations. We believe in them.

Their discoveries are already expanding our knowledge of how the brain works. They are pushing the boundaries of prevention, diagnosis and treatment of brain disorders. They are improving the health outcomes of people in Canada. Their discoveries are many, but so many mysteries remain.

This is our mission. Join us, so we can boldly explore further than we ever thought possible.

Message from Our Leaders

Brain Canada Chair

At Brain Canada, we are committed to supporting bold research for the benefit of people in Canada. Despite the pandemic challenges of 2021, this commitment to courageous ideas only intensified.

In fact, the disparities exacerbated by the pandemic, coupled with the evolving needs of high-impact research, truly underscored the importance of funding excellence – excellence that will generate positive impact and improve health outcomes for people in Canada and across the globe.

This year, Brain Canada invested more than $27.5 million in innovative research poised to contribute to major advancements in neuroscience, furthering basic knowledge and translating discoveries to enhance the health of our communities.

It was inspiring to see the number of people committed to improving brain health in Canada this past year. Brain Canada connected and convened the Canadian brain research community and its supporters at multiple engaging virtual events, including public talks, celebratory meetings, research workshops and industry panel discussions.

In 2021, our Board created a new committee to help advise us, support our work and meet the changing needs of the research community. The new Research Committee will work to reinforce Brain Canada’s invaluable role in the Canadian research ecosystem.

Among our many high-impact grants and programs, we proudly awarded five grants through the Bell Let’s Talk-Brain Canada Mental Health Research Program, the first program under Brain Canada’s new Mental Health Research Initiative. And we successfully launched the Brain Canada Youth Mental Health Platform, powered by RBC Future Launch.

We could not have done any of this without the support of our robust community of generous donors and valued partners, including Health Canada. Together, we supported some of the best and brightest minds in the country and strengthened the brain research landscape for years to come.

As Chair of Brain Canada, I want to acknowledge the remarkable community that helped us make a positive difference. Thank you for your resilience in helping us to transform brain health and your commitment to helping us change so many lives for the better.


Naomi Azrieli, DPhil
Brain Canada Chair

IT WAS INSPIRING TO SEE THE NUMBER OF PEOPLE COMMITTED TO IMPROVING BRAIN HEALTH IN CANADA THIS PAST YEAR.”
EXPLORING THE GREAT UNKNOWN THAT IS THE BRAIN CANNOT BE DONE ALONE - IT TAKES BOLD, COURAGEOUS PARTNERS TO SCALE THESE PEAKS.”

Brain Canada President and CEO

This year has been an opportune time to reflect on the work Brain Canada is doing to build a stronger future for people in Canada. More than ever, brain research is critical in helping us, as a community, recover from the COVID-19 pandemic and mitigate its effects on the brain. At Brain Canada, we envision a future where scientists across disciplines collaborate to drive innovation. A future where early-career researchers have the resources to explore their boldest ideas. And where people across the country have access to solutions that may hold the answers to mysteries like ALS, epilepsy, and brain injury.

This is the future Brain Canada envisions – the one we worked toward throughout 2021.

We are paving the way for better brain health for people in Canada by building capacity and supporting brilliant brain researchers as they explore new lines of research with enormous potential. Funding for trainees and early-career researchers through programs tailored to support the next generation of explorers is a core component of how we attract, retain, and diversify world-class talent in Canada. This year, we announced the second cohort of the Future Leaders in Canadian Brain Research Program, and, with the support of steadfast partners, we also launched the third edition of this signature program. We are already starting to see these talented early-career researchers make major contributions to neuroscience in Canada and abroad.

We believe that many brains are better than one. Open science – a movement to make research data, methods, and tools readily available for others to contribute to or use – is how we truly enable progress. By building bridges between investigators and increasing access to high-impact resources, we are pursuing new ways of thinking and new approaches to research. Through programs like the Brain Canada Youth Mental Health Platform, powered by RBC Future Launch, we are enabling researchers to share data across disciplines, including people with lived experience, to create synergies between these groups and accelerate findings that will improve youth mental health services.

Finally, we believe it is critical to invest in research that is translated into results that have concrete impacts on brain health for people in Canada. In a world where change is the only constant, our goal to improve lives through better brain health has remained unwavering. And we want to bring solutions to people living with brain diseases and disorders faster.

As we look forward, we still have so many questions to answer. But with the support of our generous donors, dedicated Board of Directors, enthusiastic partners, and incredible staff, we are getting closer and closer to the future we have imagined.


Dr. Viviane Poupon
Brain Canada President & CEO

Year in Review

2021 Highlights

It is estimated that 1 in 3 of us will experience a brain disease, disorder, or injury in our lifetime. This urgent critical need is why Brain Canada is committed to funding the most promising and innovative brain research out there, and this year was no exception.

January 1, 2021 - December 31, 2021

Success Stories

Here’s a Look at 2021

Through science, we have the potential to unlock the answers to more accurate diagnosis, prevention, and treatment solutions. Eventually, science will uncover long-hoped for cures. In the coming pages, you will discover some of the brilliant work from Brain Canada-funded researchers.

POWER TO THE PEOPLE

A new study gives Canadians the opportunity to test for Alzheimer’s and provide their perspective on how the results impacted their lives.

Over half a million Canadians are currently living with Alzheimer’s disease or a related form of dementia, and with a rapidly aging population, that number is projected to double by 2031. Now, a new test will help patients find the answers they are seeking and assist their families in planning in the face of an Alzheimer’s diagnosis.

“This is an urgent and rapidly growing health care issue,” says Dr. Mari DeMarco, a Clinical Chemist at St. Paul’s Hospital and a Clinical Associate Professor at the University of British Columbia in Vancouver, Canada. Her team developed a key component of the Alzheimer’s disease test and worked with individuals with lived experience with dementia, along with health care providers and other partners, to implement a comprehensive diagnostic testing strategy through the IMPACT-AD project, funded in part by Brain Canada. “The Alzheimer’s disease biomarker test, which we have now made available to all Canadians, can help doctors accurately diagnose the disease even when only mild symptoms are present. Through the IMPACT-AD project, our aim was to gain a better understanding of how this testing impacts personal and medical decision making, and health care costs.”

According to DeMarco, the goal of IMPACT-AD is to inform positive change in the Canadian health care system that improves care and support for individuals living with Alzheimer’s disease and their families.

Who can take the test?
The test for Alzheimer’s disease biomarkers through this program can only be ordered by a doctor specializing in dementia care. The doctor may recommend testing in individuals experiencing mild to moderate symptoms associated with Alzheimer’s disease. Measuring changes in these biomarkers in the cerebrospinal fluid, the fluid surrounding the brain and spinal cord, helps doctors identify whether the cause of the symptoms may be due to Alzheimer’s disease, and if the symptoms are likely to worsen over time.

With input from patients, their families, and their doctors, DeMarco and her colleagues are working to address barriers in the Canadian health care system.

How can the test help people experiencing memory loss and declining brain health? Early and accurate diagnosis of Alzheimer’s disease is critical because timely access to health care and community services has the potential to lead to more effective treatment and improve quality of life. Current approaches for diagnosis rely on imaging tests and observation of the signs and symptoms of the disease. Adding the measure of proteins found in cerebrospinal fluid (biomarkers) has been shown to help correctly identify the disease and predict those with mild symptoms that are likely to progress to dementia.

Read the full story
Close X
“This is an urgent and rapidly growing health care issue.”

BRAIN CANADA PLATFORM GRANTS:

Non-invasive treatment for people with depression.

Dr. Fidel Vila-Rodriguez runs the NINET (Non-Invasive Neurostimulation Therapies) Laboratory at the University of British Columbia. His promising research looks at how Transcranial Magnetic Stimulation (TMS), a non-invasive therapy, can relieve symptoms of major depression, obsessive-compulsive disorder and other mental illnesses.

In 2014, still early in his career, Dr. Vila-Rodriguez received a Brain Canada Platform Support Grant to create the Integrated Neurostimulation Platform. This critical funding established the foundation for research that can profoundly impact patients with mental illness in Canada.

A portion of the grant funded the creation of a powerful machine that combined TMS with functional magnetic resonance imaging (fMRI). Bringing the two together allows researchers to study the effects of TMS in real-time in a patient and identify new targets for stimulation.

Creating the platform was a major undertaking. Both technologies employ high-powered magnets, which have to run in delicate balance so they don’t interfere with each other. It took years of work by engineers, physicists, and more to make it operational.

The grant also funded a pilot study to use the new platform to investigate the effects of TMS when used to treat depression. The results of this study were published in the American Journal of Psychiatry in May 2022.

The study allowed Dr. Vila-Rodriguez to see what’s happening in the brain during TMS. From the first treatment, the fMRI images can also give a clue as to how effective TMS will be for a patient. From a neuroscience perspective, the project gives more insights into the workings of the brain while being stimulated. This exploration is laying the groundwork for other non-invasive treatment pathways in the future.

“This project is very close to my heart,” Dr. Vila-Rodriguez said. “It’s the first grant that I got as an early-career researcher. I put everything I had into it. Looking back, I can see how foundational it was.”

That initial investment of $277,500 has led to additional funding for a follow-up study. In addition, Dr. Vila-Rodriguez is using his hard-won knowledge to help other Canadian researchers build their own TMS-fMRI machines, multiplying the impact of the grant exponentially.

“I cannot emphasize enough how important it is to have this kind of support at the early stages of your career,” said Dr. Vila-Rodriguez. “It was so encouraging for Brain Canada to be willing to invest in something that was high risk, but also high reward.” Research platforms are important enablers of capacity building and a cost-effective means of accessing cutting-edge equipment, technology, and services beyond what individual researchers can achieve on their own.

Read the full story
Close X
“I cannot emphasize how important it is to have this kind of support.”

THINKING DIFFERENTLY

Autism in First Nations Communities.

Located in Central Alberta, the Plains Cree community of Maskwacis defines autism spectrum disorder (ASD), or pîtoteyihtam, as “he/she thinks differently.” According to Grant Bruno, a registered member of Samson Cree Nation, many people with lived experience of ASD prefer this definition over the more widely used definition from the Diagnostic and Statistical Manual of Mental Disorders.

When two of his four children were diagnosed with ASD, Grant quickly noticed that access to services within Maskwacis was very limited – ASD awareness is low, diagnosis is often delayed, and specialized support is frequently only available off reserve. Eager to learn more about the lived experience of autism in Indigenous communities, Grant turned to the literature and found that only a handful of studies had been done in Canada – even the prevalence of ASD is unknown. An MSc student at the time, Grant had not initially planned to further pursue academia but, as a member of the community himself, he felt that he was well placed to expand knowledge on ASD in First Nations communities and so the idea for his PhD project was born.

Under the supervision of Dr. Lonnie Zwaigenbaum, Professor at the University of Alberta and Brain Canada-funded researcher, and Dr. David Nicholas, a Social Work Professor at the University of Calgary, Grant aims to gather viewpoints that will improve our understanding of ASD in First Nations communities. To fully capture the reality of living or caring for someone with autism in Maskwacis, Grant will engage with the community at all levels, namely community leaders and members, Elders, knowledge keepers, as well as health care and education providers and children and their families.

Though historically research was done on Indigenous communities rather than with them, which led to it not being representative, Grant will be using a strengths-based decolonizing approach rooted in community-based participatory research methods to make sure that the research is done through the community, by the community, and for the community. To Grant, allowing the community to guide the research is crucial. “I am from there and I am mindful of how I’m representing the community,” he said. “I need my research to really allow the community to tell their stories.”

By engaging with and collecting data from individuals, families and professionals associated with ASD in the First Nations context, this work will provide unique and informative perspectives on the strengths and challenges of what it means to experience autism within these communities. Armed with this knowledge, Grant aims to influence policy within and outside Maskwacis, and to provide evidence for the kinds of services that are needed by the community.

Read the full story
Close X
“Research has been very healing for me. I’ve been able to really immerse myself in the rich culture of Maskwacis.”

CLEARING THE FoG

Illuminating the unique “signature” of freezing of gait for Canadians with Parkinson’s disease.

For more than two decades, doctors have been able to reduce many symptoms of Parkinson’s disease through deep brain stimulation (DBS). DBS uses implanted electrodes to deliver electrical stimulation deep within the brain. But one symptom continues to elude treatment: “freezing of gait” (FoG), which makes it hard to walk and can lead to dangerous falls.

In order to clear the FoG, Luka Milosevic, a researcher with University Health Network in Toronto, is deploying a new kind of electric stimulation, better attuned to FoG’s distinctive signature. This could result in advancements in taming a disease that robs more than 100,000 Canadians of many aspects of their normal life and dignity.

In the past two years, advancements in the medical device industry are allowing DBS implants to not only deliver stimulation, but to perform wireless readings of brain activity in real time. Previously, wires or bulky machines would impede a patient’s ability to freely walk around while recording brain activity, making the causes of FoG notoriously difficult to pinpoint – and treat. The new technology will help illuminate the unique “signature” of FoG in the brain and highlight potential areas and strategies for targeted stimulation.

“FoG is a very stubborn feature of the disease, which made me interested in trying to understand the neural underpinnings of these gait difficulties,” explained Dr. Milosevic. “Perhaps once we understand more about the physiological features, then we can develop targeted therapies to ameliorate the symptom.”

Beyond the implications for FoG, Dr. Milosevic said the study could lead to a more sophisticated application of DBS for all Parkinson’s symptoms.

Currently, DBS indiscriminately delivers stimulation 24 hours a day. However, if researchers can learn more about which brain activity is tied to particular symptoms, they can deliver targeted stimulation only when necessary.

This shift could help preserve a device’s battery life – a critical need, as changing a device’s batteries requires surgery – and help reduce the already minimal side effects of DBS.

“The number one priority is to improve a patient’s gait, to give them their mobile independence back and enhance their quality of life,” said Dr. Milosevic. “But this study also signals a strategic shift in DBS delivery methods. We want to advance the technology as a whole. This will have implications on any symptom and any brain disorder in which DBS is a potential therapeutic option.”

“By providing this support, we are giving promising researchers the jump-start they need to explore daring, innovative and high-potential lines of research,” said Dr. Viviane Poupon, Brain Canada President and CEO.

Read the full story
Close X
“This grant gave me the opportunity to do something that is truly exciting for me, and that I know is a health care priority.”
To read all 15 success stories, download the PDF
WE’RE LIKE EARLY EXPLORERS IN SEARCH OF A BETTER LIFE. YOU NEVER KNOW WHAT WILL COME NEXT.”
Dr. Nader Ghasemlou
Assistant Professor, Queen’s University and Future Leader in Canadian
Brain Research Grant recipient.

Fundraising and Outreach

Top 10 Community Impact Highlights

Canada is among the world’s five most active countries in neuroscience. Canadian researchers have contributed to major scientific advancements in brain research that have furthered the field both nationally and internationally. Brain Canada plays an invaluable, critical role in this success. As a national convenor and enabler of innovative and bold neuroscience, Brain Canada has established a transformative research funding model with the support of the federal government and other dedicated partners and donors—a model with a proven track record of accelerating brain research. We have our dedicated and inspiring community to thank for helping us achieve better health outcomes for all people in Canada.

THE MOST EFFECTIVE WAY TO DO IT, IS TO DO IT.”
Amelia Earhart
American aviation pioneer and author

20 BRILLIANT CANADIANS

Anchored by a lead gift from the Azrieli Foundation, with support from The Arrell Family Foundation and the Alvin Segal Family Foundation, Brain Canada’s Future Leaders in Canadian Brain Research Program is providing early-career researchers with the jump start they need.

THE TIME TO ACT IS NOW

The Brain Canada Youth Mental Health Platform program, powered by RBC Future Launch was established this year thanks to a new $2 million anchor gift from the RBC Foundation, in support of RBC Future Launch. Power Corporation recently joined in partnership to further fuel this initiative toward greater impact with a $1 million gift.

A HEALTHIER AND STRONGER CANADA

Thanks to a new $2.2 million gift from Bell Let's Talk, collaborative and multi- disciplinary research teams across Canada received a funding boost through the Bell Let's Talk - Brain Canada Mental Health Research Program to support emerging scientific knowledge that will meet the rising demand for evidence-based mental health treatment options.

MEANINGFUL CUTTING-EDGE RESEARCH FOR CANADIAN YOUTH

Under a common goal and vision, Brain Canada and The Erika Legacy Foundation are joining forces for the first time to leverage each other's strengths and deepen Canadians' understanding of mental illness.

SUPPORT FOR FUTURE CANADIAN NEUROSCIENTISTS

The late Dr. Hubert van Tol, Professor and Canada Research Chair in Neurobiology at the University of Toronto, spent his career developing a profound appreciation for collaborating with international colleagues. Following his death in 2006, his family commemorated his legacy with Brain Canada through the Dr. Hubert van Tol Travel Fellowship.

CHANGING OUR BRAINS FOR THE BETTER

With a generous gift from the Galati Family and by collaborating closely with Brain Changes Initiative and leveraging the organization’s knowledge of people with lived experience of Traumatic Brain Injury (TBI), Brain Canada is working to create change in how we share evidence that can lead to breakthroughs and support the implementation of effective health care services in Canada.

To read all 10 community impact highlights, download the PDF
THE GREATEST DISCOVERIES ALL START WITH THE QUESTION WHY?”
Robert Ballard
Explorer, retired Navy Officer & Professor of Oceanography
University of Rhode Island

Governance

Leading With Purpose

To ensure adherence to all policies and guidelines, members of the Board and its committees are determined to remain effective in their overall governance of Brain Canada and conduct a thorough self-evaluation on an annual basis. Brain Canada requires any Board member who has a potential conflict of interest to disclose the conflict publicly and abstain from voting on any matter where there is a conflict or potential conflict of interest.

Brain Canada’s Board of Directors volunteers its time and expertise to provide strategic advice and oversight to the Foundation. The Board is committed to ensuring Brain Canada’s success as a leading brain research convenor and in supporting its engagement with the brain research community, stakeholders and the broader public.

Composed of leaders from the business, academic, scientific, philanthropic and Indigenous communities, the Board adheres to Brain Canada’s Code of Conduct. Its members uphold the highest standards of honesty, integrity, ethics and professional management.

In addition to meeting four times a year for standing Board meetings, Directors also sit on various committees:

The Governance, Nominating and Ethics Committee (GNEC)
A committee that assists the Board on all matters relating to governance and leadership, as well as ensuring the highest ethical standards.

The Audit, Finance, Investment and Risk Management Committee (AFIRM)
A committee that provides support to the Board to ensure financial and organizational viability by overseeing the annual audit, budgets, treasuries, policies, key financial controls, key role succession and risk management. The Committee reports to the Board of Directors and recommends the appointment of auditors to review the annual financial statements.

The Research Committee (RC)
The Research Committee provides support to the Board in fulfilling its responsibilities on the broad perspective of research at Brain Canada. The RC makes recommendations to the Board on matters of research policy as well as provides oversight on the value and impact of Brain Canada funded research. It also supports the board by providing advice regarding new and emerging themes and directions in brain research, as well as opportunities for differentiation within the Canadian research landscape.

AN EXPLORER IS SOMEONE WHO SEEKS THE TRUTH, EVEN IF IT RISKS CHALLENGING CURRENT IDEAS AND PERCEPTIONS.”
Dr. Sue-Ann Mok
Assistant Professor, University of Alberta and Future Leader in Canadian Brain Research Grant recipient
I LIKE TO EXPLORE ASPECTS
OF SCIENCE THAT COULD LEAD TO NEW DISCOVERIES.”
Dr. Chantelle Sephton
Associate Professor, Université Laval and Future Leader
in Canadian Brain Research Grant recipient

Our Donors

Change Starts Here

Thanks to steady support from donors, Brain Canada has continued its quest to better understand the brain in illness and health. Our donors empower Brain Canada to invest in next-generation investigators, capacity building initiatives, innovative research teams and unique partnerships that drive brain research forward. With your support, we make strides that will ultimately improve health outcomes for Canadians.

We gratefully acknowledge the cumulative contributions of our lead donors, who have supported Brain Canada over the years.

DON’T LET ANYONE ROB YOU OF YOUR IMAGINATION, YOUR CREATIVITY, OR YOUR CURIOSITY.”
Mae Jemison
First African-American woman to travel in space

Lead Donors

Cumulative giving 2011 – December 31, 2021

The Azrieli Foundation
$12,575,000
The Chagnon Family
$5,000,000
Krembil Foundation
$4,110,000
W. Garfield Weston Foundation
$3,000,000
RBC Foundation
$2,795,500
(includes $2M gift in 2021)

Bell Canada/ Bell Let’s Talk
$2,800,000
(includes $2.2M gift in 2021)
Anonymous (2)
$1,931,000
Power Corporation
$1,150,000
The Estate of Donna Canary
$1,078,000

The Galati Family
$848,000
CIBC
$525,000
Rossy Foundation
$505,000
Arrell Family Foundation
$320,000

I AM COMPELLED TO ASK QUESTIONS AND FIND THE ANSWERS. MOST OF ALL, TO NEVER GIVE UP.”
Dr. Benoit Laurent
Assistant Professor, Université de Sherbrooke and Future Leader
in Canadian Brain Research Grant recipient

Our Partners

Bringing It All Together

Making a significant difference in the lives of Canadians doesn’t happen in a vacuum. It takes a network of visionary partners committed to investing in change. As a national convener and facilitator, Brain Canada worked with partners from coast to coast to drive innovative brain research in 2021. Partners are critical in enabling our mission to bring together the brightest minds and best ideas to help us better understand how to prevent, diagnose, treat and cure brain diseases and disorders.

Canada Brain Research Fund Overview
The Canada Brain Research Fund (CBRF) is an innovative arrangement between the Government of Canada (through Health Canada) and Brain Canada Foundation. To date, Health Canada has invested over $130 million through CBRF, which has been matched by Brain Canada Foundation and its donors and partners. CBRF is designed to increase Canadians’ support of brain research and maximize the impact and efficiency of those investments. This visionary commitment by the federal government has ensured that Canada has been and will continue to be among the leaders in the global challenge to understand brain function and brain diseases.

THIS MAY LOOK LIKE A SUNSET, BUT IT’S
A NEW DAWN.”
Chris Hadfield
Retired Canadian astronaut, engineer and fighter pilot

Thank You!

We like to offer gratitude to the many individuals who have made donations in honour of a loved one and to those who have steadily Supported Brain Canada throughout the years.

Learn more:

Download the full annual report

View past annual reports

Visit Braincanda.ca

Donate

Subscribe

Brain Canada © 2022   Registration Number: 89105 2094 RR0001

Brain Canada is a national registered charity that enables and supports excellent, innovative, paradigm-changing brain research in Canada.

Production of this Annual Report has been made possible with the financial support of Health Canada through the Canada Brain Research Fund.

The views expressed herein do not necessarily represent the views of the Minister of Health or the Government of Canada.

Linkedin Twitter Facebook Instagram
Scroll home